| Ticker: | VTVT |
| Current Price: | $19.69 |
| % Daily Change: | -4.83% |
| Volume (1,000s): | 17.40 |
| Average Volume (1,000s): | 56.16 |
| Market Cap (M): | $77.85 |
| 1/2/2024 Price: | $10.80 |
| Change Since Inception: | 82.31% |
vTv Therapeutics Inc.
3980 Premier Drive
Suite 310
High Point, NC 27265
United States
vTv is a clinical stage biotechnology company with a pipeline of drug candidates led by TTP399, a potentially transformative treatment for the reduction of hypoglycemic episodes in type 1 diabetes patients.